Abstract

The disease-causing blood-stage of the Plasmodium falciparum lifecycle begins with invasion of human erythrocytes by merozoites. Many vaccine candidates with key roles in binding to the erythrocyte surface and entry are secreted from the large bulb-like rhoptry organelles at the apical tip of the merozoite. Here we identify an essential role for the conserved protein P. falciparum Cytosolically Exposed Rhoptry Leaflet Interacting protein 1 (PfCERLI1) in rhoptry function. We show that PfCERLI1 localises to the cytosolic face of the rhoptry bulb membrane and knockdown of PfCERLI1 inhibits merozoite invasion. While schizogony and merozoite organelle biogenesis appear normal, biochemical techniques and semi-quantitative super-resolution microscopy show that PfCERLI1 knockdown prevents secretion of key rhoptry antigens that coordinate merozoite invasion. PfCERLI1 is a rhoptry associated protein identified to have a direct role in function of this essential merozoite invasion organelle, which has broader implications for understanding apicomplexan invasion biology.

Rhoptries are essential organelles for invasion of erythrocytes by Plasmodium. Here, the authors characterize the rhoptry-associated protein CERLI1 using quantitative super-resolution microscopy, showing that it is important for parasite invasion and secretion of rhoptry proteins including vaccine antigens.

Details

Title
PfCERLI1 is a conserved rhoptry associated protein essential for Plasmodium falciparum merozoite invasion of erythrocytes
Author
Liffner Benjamin 1   VIAFID ORCID Logo  ; Frölich Sonja 1   VIAFID ORCID Logo  ; Heinemann, Gary K 2 ; Liu Boyin 3 ; Ralph, Stuart A 3   VIAFID ORCID Logo  ; Dixon Matthew W A 3   VIAFID ORCID Logo  ; Tim-Wolf, Gilberger 4 ; Wilson, Danny W 5   VIAFID ORCID Logo 

 University of Adelaide, Research Centre for Infectious Diseases, School of Biological Sciences, Adelaide, Australia (GRID:grid.1010.0) (ISNI:0000 0004 1936 7304) 
 University of South Australia Cancer Research Institute, Experimental Therapeutics Laboratory, School of Pharmacy and Medical Sciences, Adelaide, Australia (GRID:grid.1026.5) (ISNI:0000 0000 8994 5086) 
 The University of Melbourne, Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
 Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany (GRID:grid.424065.1) (ISNI:0000 0001 0701 3136); Centre for Structural Systems Biology, Hamburg, Germany (GRID:grid.424065.1); University of Hamburg, Biology Department, Hamburg, Germany (GRID:grid.9026.d) (ISNI:0000 0001 2287 2617) 
 University of Adelaide, Research Centre for Infectious Diseases, School of Biological Sciences, Adelaide, Australia (GRID:grid.1010.0) (ISNI:0000 0004 1936 7304); Burnet Institute, Melbourne, Australia (GRID:grid.1056.2) (ISNI:0000 0001 2224 8486) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2377671745
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.